Search Results - "BOCCUZZI, S. J"

Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease by Sueta, Carla A, Chowdhury, Mridul, Boccuzzi, Stephen J, Smith, Sidney C, Alexander, Charles M, Londhe, Anil, Lulla, Ash, Simpson, Ross J

“…There is a lack of data evaluating the implementation of guidelines in the management of coronary artery disease (CAD) or congestive heart failure (CHF) in the…”
Get full text

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease by Treasure, C.B. (Emory University School of Medicine, Atlanta.), Klein, J.L, Weintraub, W.S, Talley, J.D, Stillabower, M.E, Kosinski, A.S, Zhang, J, Boccuzzi, S.J, Cedarholm, J.C, Alexander, R.W

“…Impaired endothelium-mediated relaxation contributes to vasospasm and myocardial ischemia in patients with coronary artery disease. We hypothesized that…”
Get full text

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography : the Canadian coronary atherosclerosis intervention trial by WATERS, D, HIGGINSON, L, GLADSTONE, P, KIMBALL, B, LE MAY, M, BOCCUZZI, S. J, LESPERANCE, J

“…3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors are widely prescribed for hyperlipidemia, yet their effect on the evolution of coronary…”
Get full text

Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study by HERMAN, W. H, ALEXANDER, C. M, COOK, J. R, BOCCUZZI, S. J, MUSLINER, T. A, PEDERSEN, T. R, KJEKSHUS, J, PYÖRALÄ, K

“…Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin…”
Get full text

Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study by Haffner, S M, Alexander, C M, Cook, T J, Boccuzzi, S J, Musliner, T A, Pedersen, T R, Kjekshus, J, Pyörälä, K

“…Patients with diabetes mellitus (DM) have a marked increase in coronary heart disease (CHD) events relative to those without DM. In a previous report from the…”
Get more information

Effects of cholesterol lowering on the progression of coronary atherosclerosis in women : a Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) substudy by WATERS, D, HIGGINSON, L, GLADSTONE, P, BOCCUZZI, S. J, COOK, T, LESPERANCE, J

“…Although coronary disease is the leading cause of death in women and its clinical features differ from those in men, very few women have been included in…”
Get full text

Can cardiovascular clinical characteristics be identified and outcome models be developed from an in-patient claims database? by Weintraub, William S, Deaton, Christi, Shaw, Leslee, Mahoney, Elizabeth, Morris, Douglas C, Saunders, Candice, Canup, Debbie, Connolly, Stephanie, Culler, Steven, Becker, Edmund R, Kosinski, Andrzej, Boccuzzi, Stephen J

“…The objective of this study was to assess whether administrative (claims) databases can be used to assess clinical variables and predict outcome. Although…”
Get full text

Long-term safety and efficacy profile of simvastatin by Boccuzzi, Stephen J., Bocanegra, Tomas S., Walker, J.Findlay, Shapiro, Deborah R., Keegan, Maureen E.

“…Simvastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, has been administered to approximately 2,400 patients with primary…”
Get full text

Targeting patients undergoing angioplasty for thrombus inhibition: A cost-effectiveness and decision support model by WEINTRAUB, W. S, THOMPSON, T. D, CULLER, S, BOCCUZZI, S. J, BECKER, E. R, KOSINSKI, A. S, MAHONEY, E

“…In recent clinical trials, glycoprotein IIb/IIIa blockers have demonstrated effectiveness in preventing adverse events after angioplasty in high-risk patients…”
Get full text

Utilization of Oral Hypoglycemic Agents in a Drug-Insured U.S. Population by BOCCUZZI, Stephen J, WOGEN, Jenifer, FOX, James, SUNG, Jennifer C. Y, SHAH, Amishi B, KIM, Jennifer

“…Utilization of Oral Hypoglycemic Agents in a Drug-Insured U.S. Population Stephen J. Boccuzzi , PHD 1 , Jenifer Wogen , MS 1 , James Fox , MPH 1 , Jennifer…”
Get full text

Costs of coronary restenosis (Lovastatin Restenosis Trial) by Gilbert, Susan P., Weintraub, William S., Talley, J.David, Boccuzzi, Stephen J.

“…Within the Lovastatin Restenosis Trial, restenosis has been clearly shown to increase resource utilization and costs. While it is not possible to generalize…”
Get full text

Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medications by Boccuzzi, Stephen J., Wogen, Jenifer, Roehm, James B.

“…This study was undertaken to assess drag-use patterns associated with albuterol delivery via a new propellant device compared with conventional…”
Get full text

Aggressive Lipid Lowering in Postcoronary Angioplasty Patients With Elevated Cholesterol (the Lovastatin Restenosis Trial) by Boccuzzi, Stephen J, Weintraub, William S, Kosinski, Andrzej S, Roehm, James B, Larry Klein, J

“…A substudy of the Lovastatin Restenosis Trial in patients with elevated cholesterol (>200 mg/dl) showed no evidence of an effect of aggressive lipid lowering…”
Get full text

Performance Assessment Model for Guideline-Recommended Pharmacotherapy in the Secondary Prevention of Coronary Artery Disease and Treatment of Left Ventricular Dysfunction by Simpson, Ross J., Sueta, Carla A., Boccuzzi, Stephen J., Lulla, Ash, Biggs, David, Londhe, Anil, Smith, Sidney C.

“…The Agency for Health Care Policy and Research, the National Heart Lung and Blood Institute of the National Institutes of Health, the American Heart…”
Get full text

Frequency of Concurrent Use of Warfarin with Potentially Interacting Drugs by Wittkowsky, Ann K., Boccuzzi, Stephen J., Wogen, Jenifer, Wygant, Gail, Patel, Pankaj, Hauch, Ole

“…Study Objective. To determine the rates of concomitant use of drugs known to interact with warfarin by increasing the prothrombin time expressed as the…”
Get full text

Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina with Aggrastat ® [tirofiban] and Determine Cost of Therapy with Invasive or Conservative Strategy)–TIMI 18 trial by Weintraub, William S, Culler, Steven D, Kosinski, Andrzej, Becker, Edmund R, Mahoney, Elizabeth, Burnette, Joy, Spertus, John A, Feeny, David, Cohen, David J, Krumholz, Harlan, Ellis, Stephen G, Demopoulos, Laura, Robertson, Deborah, Boccuzzi, Stephen J, Barr, Eliav, Cannon, Christopher P

“…Concern over escalating health care costs has led to increasing focus on economics and assessment of outcome measures for expensive forms of therapy. This is…”
Get full text

Serial acquisition of data to predict one-year mortality rate after acute myocardial infarction by Tibbits, Paul A., Evaul, Judy E., Goldstein, Robert E., Boccuzzi, Stephen J., Therneau, Terry M., Parker, Roger, Wong, Dean

“…Eight hundred sixty-six patients with acute myocardial infarction (AMI) were enrolled in a prospective study to determine optimal predictors of long-term…”
Get full text

Angiotensin-converting enzyme inhibitors in the management of congestive heart failure: A pharmaceutical industry perspective by Boccuzzi, Stephen J.

Get full text

Noninvasive and angiographic evaluation of coronary artery disease in patients with peripheral vascular disease by Youngman, Darrell J., Dove, Thomas, Boccuzzi, Stephen J., Price, Herman L.

“…The accuracy of exercise testing for detection of coronary artery disease in a population with a high incidence of claudication was evaluated in 58 consecutive…”
Get full text

Pacemaker-induced sustained ventricular tachycardia by Tibbits, Paul A., Elizabeth O'Brien, Mary, Boccuzzi, Stephen J., Messersmith, Donald P., Baker, William P.

Get full text